- About bilaterals.org
- How to participate
- Key issues
- Texts of agreements
Millions will die if India stops AIDS drugs — UN
- A sex worker holds a placard during an AIDS awareness rally to mark the World AIDS Day in Siliguri December 1, 2008. REUTERS/Rupak De Chowdhuri/Files
Millions will die if India stops AIDS drugs — U.N.
By Nita Bhalla
NEW DELHI | Tue Jul 5, 2011
(Reuters) — Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday.
The EU and India are currently negotiating a free-trade agreement, which campaigners say will restrict India’s ability to produce anti-retroviral (ARV) drugs, preventing the world’s poor from accessing cheap drugs for their treatment.
"India should resist removing any flexibility because any trade agreement which could lead to India not being able to produce will be terrible for the rest of the world," said Michel Sidibe, executive director for the Joint United Nations Programme on HIV/AIDS (UNAIDS).
"Millions of people will die if India cannot produce and Africa will be the most affected. For me, it is an issue of life or death," he told Reuters in an interview, adding that about 86 percent of people on treatment were taking drugs made in India.
The EU-India trade deal includes measures that could delay or restrict competition from generic medicines by extending patent terms, requiring data exclusivity and tightening border enforcement rules.
Such moves could drive up prices for India’s anti-retroviral treatments, limit dosage options and delay access to newer and better drugs, said a U.N. report in September last year.
REVERSING GAINS MADE
Thirty years after the HIV/AIDS virus was first discovered, experts say while substantial progress has been made by the global community in stemming it, only a fraction of those living with the illness are on medication.
At a high level U.N. meeting last month, nations agreed on a set of ambitious targets to rid the world of disease, including scaling up the provision of generics to reach 15 million patients from six million by 2015.
The trade deal, Sidibe said, would reverse many of the gains made in improving the lives of the world’s poor.
"We have been fighting for so long to make sure that poor people could have access to treatment," he said. "For me, it will be the beginning of reversing all the gains we made on social justice and redistribution of opportunity."
Sidibe, a Mali national, said African leaders were asking India to really pay serious attention to any trade agreement which would block them to produce quality generic drugs for very poor people.
"It is not a rich pocket of people in the developed world who will be deprived of drugs, it will be the most needy, the most poor."
(Editing by Yoko Nishikawa)
bilaterals.org and a new ISDS (investor-state dispute settlement) platform to be hosted at bilaterals.org seek to hire a coordinator for their work. This is a great opportunity for someone interested in working on a full-time, paid basis to support people’s struggles against so-called free trade and investment deals globally, through a job share for two separate but complementary projects.
Find out more.
News from the movements
27-Aug-2015 Blastingnews.comUna Iniciativa Ciudadana Europea pide apoyos para frenar el TTIP y el CETA.
26-Aug-2015 TNIWhile TTIP is currently the center of attention, our world leaders discuss TiSA, an extensive service agreement meant to put (public) services, like the water supply, in the hands of the international market.
25-Aug-2015 Rojo y Negro
Del 10 al 17 de octubre unámonos a las marchas, manifestaciones masivas y organicemos acciones locales por toda EuropaDel 10 al 17 de octubre unámonos a las marchas, manifestaciones masivas y organicemos acciones locales por toda Europa y América del Norte. ¡No al TTIP, CETA, TPP y TISA!
24-Aug-2015 MSFDoctors Without Borders/Médecins Sans Frontières (MSF) is calling for the removal of damaging intellectual property provisions in the Regional Comprehensive Economic Partnership (RCEP) that would risk locking in high drug prices.
24-Aug-2015 CEOOfficiellement, les lobbys des entreprises vantent à qui veut l’entendre les bienfaits du TTIP / TAFTA pour les petites et moyennes entreprises (PME). En coulisses, ils admettent la triste réalité : les avantages restent hypothétiques.
24-Aug-2015 FacebookBy journalist Bryan Bruce
24-Aug-2015 Sydney Morning HeraldMore than one hundred protesters gathered in Martin Place, Australia on Sunday to rally in opposition against the Trans-Pacific Partnership calling for the deal to be "scrapped entirely."
23-Aug-2015 Public CitizenThe status quo trade model’s 21-year record of massive U.S. trade deficits, job loss and wage suppression.
bilaterals.org is a collaborative space to share information and support movements struggling against bilateral trade and investment deals which serve corporations, not people. Multilingual. Global. No one owns it. Open publishing. Get involved.